专业监测看板

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

药物 / 成分：Intraurethral lidocaine gel alone、Intraurethral lidocaine gel + lidocaine 2% injection、intraurethral lidocaine gel + liquid paraffinl

登记的停止原因（原文）：The standard measures of anaesthesia in cystoscopy are not uniform internationally, and given this, we were unable to recruit the first participant in the study.

Beta-blocker vs. Ic Antiarrhythmic Drug for PVC

药物 / 成分：Propafenone、Indenol

Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission

药物 / 成分：Hydroxocobalamin with Butyrate、Placebo with Butyrate

登记的停止原因（原文）：Decision to pursue a smaller scale pilot study instead

Pupillometry Guided Remifentanil Administration In Pediatric Anesthesia

药物 / 成分：Remifentanil、Pupillometry、Sevoflurane

登记的停止原因（原文）：Principal investigator left the institution

Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

药物 / 成分：SCM-010

登记的停止原因（原文）：Due to sponsor decision

SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery

药物 / 成分：Aspirin 81Mg Ec Tab、Standard of Care

登记的停止原因（原文）：Limited Resources

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

药物 / 成分：SM-1、Placebo

登记的停止原因（原文）：no participants enrolled

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise

药物 / 成分：COVI-MSC、Placebo

登记的停止原因（原文）：Sorrento Therapeutics filed for chapter 11 bankruptcy.

A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors

药物 / 成分：tepotinib、tepotinib plus osimertinib

登记的停止原因（原文）：0 participant accrual

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

药物 / 成分：ADX-629

登记的停止原因（原文）：Lack of enrollment.

A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors

药物 / 成分：[14C]CC-90010、CC-90010

登记的停止原因（原文）：Business Objectives have changed.

Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome

药物 / 成分：LY3361237

登记的停止原因（原文）：Drug unavailable

Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)

药物 / 成分：ARO-SOD1 Injection

登记的停止原因（原文）：Company business decision

Delaying the Onset of Nearsightedness Until Treatment Study

药物 / 成分：Atropine Ophthalmic

登记的停止原因（原文）：sIRB determined feasibility study could not be done because of no benefits of the treatment drops in short time violated FDA requirements

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

药物 / 成分：Allogeneic NK（CCT-ANK-11)

登记的停止原因（原文）：The project is terminated

Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury

药物 / 成分：Platelet Rich Plasma、Saline Placebo

登记的停止原因（原文）：COVID-19, Lack of Funding

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

药物 / 成分：TJ271 Injection in Combination with Pembrolizumab

登记的停止原因（原文）：Company Development strategy adjustment

Donepezil Trial for Motor Recovery in Acute Stroke

药物 / 成分：Donepezil、Placebo

登记的停止原因（原文）：No financial support

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

药物 / 成分：Best Practice、Nicotine Replacement、Quality-of-Life Assessment、Questionnaire Administration

登记的停止原因（原文）：Funding lapse

A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery

药物 / 成分：Levofloxacin Ocular Implant、Control

登记的停止原因（原文）：Sponsor has suspended study to conserve capital for clinical development of lead asset